Related Experiment Video
Updated: Jun 19, 2026
08:37
Blood Circuit Reconstruction in an Abdominal Mouse Heart Transplantation Model
Published on: June 3, 2021
Heart transplantation using bivalirudin as anticoagulant
Sinan A Simsir1, Ernst R Schwarz, Lawrence S C Czer
1Division of Cardiothoracic Surgery, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA. Sinan.simsir@cshs.org
Interactive Cardiovascular and Thoracic Surgery
|October 3, 2009
Summary
A patient with heparin-induced thrombocytopenia (HIT) and cardiomyopathy received a successful heart transplant. Bivalirudin was used as an anticoagulant, demonstrating its efficacy in complex cardiovascular cases.
Area of Science:
- Cardiology
- Hematology
Background:
- Heparin-induced thrombocytopenia (HIT) is a serious immune complication of heparin therapy.
- Acute idiopathic decompensated cardiomyopathy presents a significant challenge for heart transplantation candidates.
Observation:
- The case involved a male patient diagnosed with both HIT and acute idiopathic decompensated cardiomyopathy.
- The patient required a heart transplant due to severe cardiac dysfunction.
Findings:
- Successful heart transplantation was achieved in this high-risk patient.
- Bivalirudin was employed as the primary anticoagulant agent throughout the perioperative period.
- The use of bivalirudin was associated with a favorable outcome, avoiding heparin-related complications.
Implications:
- This case highlights the potential of bivalirudin as a safe and effective anticoagulant in patients with HIT undergoing major cardiovascular surgery.
- It suggests a viable management strategy for heart transplant recipients with contraindications to traditional anticoagulants.
- Further research into bivalirudin's role in HIT patients undergoing transplantation is warranted.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...